These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

251 related items for PubMed ID: 24831847

  • 1. Expression of gut-homing β7 receptor on T cells: surrogate marker for microbial translocation in suppressed HIV-1-infected patients?
    Abad-Fernández M, Gutiérrez C, Madrid N, Hernández-Novoa B, Díaz L, Muñoz-Fernández MA, Moreno S, Vallejo A.
    HIV Med; 2015 Jan; 16(1):15-23. PubMed ID: 24831847
    [Abstract] [Full Text] [Related]

  • 2. The effect of intensification with raltegravir on the HIV-1 reservoir of latently infected memory CD4 T cells in suppressed patients.
    Vallejo A, Gutierrez C, Hernandez-Novoa B, Diaz L, Madrid N, Abad-Fernandez M, Dronda F, Perez-Elias MJ, Zamora J, Muñoz E, Muñoz-Fernandez MA, Moreno S.
    AIDS; 2012 Sep 24; 26(15):1885-94. PubMed ID: 22992577
    [Abstract] [Full Text] [Related]

  • 3. Correlation between different methods to measure microbial translocation and its association with immune activation in long-term suppressed HIV-1-infected individuals.
    Abad-Fernández M, Vallejo A, Hernández-Novoa B, Díaz L, Gutiérrez C, Madrid N, Muñoz MA, Moreno S.
    J Acquir Immune Defic Syndr; 2013 Oct 01; 64(2):149-53. PubMed ID: 24047967
    [Abstract] [Full Text] [Related]

  • 4. Altered CD4+ T cell homing to the gut impairs mucosal immune reconstitution in treated HIV-infected individuals.
    Mavigner M, Cazabat M, Dubois M, L'Faqihi FE, Requena M, Pasquier C, Klopp P, Amar J, Alric L, Barange K, Vinel JP, Marchou B, Massip P, Izopet J, Delobel P.
    J Clin Invest; 2012 Jan 01; 122(1):62-9. PubMed ID: 22156200
    [Abstract] [Full Text] [Related]

  • 5. Peripheral Th17 cells expressing β7 intestinal homing receptor in recent and chronic HIV infections.
    Márquez-Coello M, Montes-de-Oca Arjona M, Fernández-Gutiérrez Del Álamo C, Ruiz-Sánchez C, Girón-González JA.
    Clin Exp Immunol; 2018 Dec 01; 194(3):350-360. PubMed ID: 30101536
    [Abstract] [Full Text] [Related]

  • 6. Preservation of Gastrointestinal Mucosal Barrier Function and Microbiome in Patients With Controlled HIV Infection.
    Mak G, Zaunders JJ, Bailey M, Seddiki N, Rogers G, Leong L, Phan TG, Kelleher AD, Koelsch KK, Boyd MA, Danta M.
    Front Immunol; 2021 Dec 01; 12():688886. PubMed ID: 34135912
    [Abstract] [Full Text] [Related]

  • 7. Gut Homing CD4+ and CD8+ T-Cell Frequencies in HIV Infected Individuals on Antiretroviral Treatment.
    Briceño O, Pinto-Cardoso S, Rodríguez-Bernabe N, Murakami-Ogasawara A, Reyes-Terán G.
    PLoS One; 2016 Dec 01; 11(11):e0166496. PubMed ID: 27898686
    [Abstract] [Full Text] [Related]

  • 8. Treatment-Naïve HIV-Infected Patients Have Fewer Gut-Homing β7 Memory CD4 T Cells than Healthy Controls.
    Fadul N, Couturier J, Yu X, Kozinetz C, Arduino R, Lewis DE.
    South Med J; 2017 Nov 01; 110(11):709-713. PubMed ID: 29100221
    [Abstract] [Full Text] [Related]

  • 9. Effect of raltegravir intensification on HIV proviral DNA in the blood and gut mucosa of men on long-term therapy: a randomized controlled trial.
    Chege D, Kovacs C, la Porte C, Ostrowski M, Raboud J, Su D, Kandel G, Brunetta J, Kim CJ, Sheth PM, Kaul R, Loutfy MR.
    AIDS; 2012 Jan 14; 26(2):167-74. PubMed ID: 22089379
    [Abstract] [Full Text] [Related]

  • 10. Brief Report: A High Rate of β7+ Gut-Homing Lymphocytes in HIV-Infected Immunological Nonresponders is Associated With Poor CD4 T-Cell Recovery During Suppressive HAART.
    Girard A, Vergnon-Miszczycha D, Depincé-Berger AE, Roblin X, Lutch F, Lambert C, Rochereau N, Bourlet T, Genin C, Paul S.
    J Acquir Immune Defic Syndr; 2016 Jul 01; 72(3):259-65. PubMed ID: 27306505
    [Abstract] [Full Text] [Related]

  • 11. Sigmoid Th17 populations, the HIV latent reservoir, and microbial translocation in men on long-term antiretroviral therapy.
    Chege D, Sheth PM, Kain T, Kim CJ, Kovacs C, Loutfy M, Halpenny R, Kandel G, Chun TW, Ostrowski M, Kaul R, Toronto Mucosal Immunology Group.
    AIDS; 2011 Mar 27; 25(6):741-9. PubMed ID: 21378536
    [Abstract] [Full Text] [Related]

  • 12. Treatment intensification with raltegravir in subjects with sustained HIV-1 viraemia suppression: a randomized 48-week study.
    Llibre JM, Buzón MJ, Massanella M, Esteve A, Dahl V, Puertas MC, Domingo P, Gatell JM, Larrouse M, Gutierrez M, Palmer S, Stevenson M, Blanco J, Martinez-Picado J, Clotet B.
    Antivir Ther; 2012 Mar 27; 17(2):355-64. PubMed ID: 22290239
    [Abstract] [Full Text] [Related]

  • 13. Impaired gut junctional complexes feature late-treated individuals with suboptimal CD4+ T-cell recovery upon virologically suppressive combination antiretroviral therapy.
    Tincati C, Merlini E, Braidotti P, Ancona G, Savi F, Tosi D, Borghi E, Callegari ML, Mangiavillano B, Barassi A, Bulfamante G, d'Arminio Monforte A, Romagnoli S, Chomont N, Marchetti G.
    AIDS; 2016 Apr 24; 30(7):991-1003. PubMed ID: 27028142
    [Abstract] [Full Text] [Related]

  • 14. Gut Lactobacillales are associated with higher CD4 and less microbial translocation during HIV infection.
    Pérez-Santiago J, Gianella S, Massanella M, Spina CA, Karris MY, Var SR, Patel D, Jordan PS, Young JA, Little SJ, Richman DD, Smith DM.
    AIDS; 2013 Jul 31; 27(12):1921-31. PubMed ID: 24180001
    [Abstract] [Full Text] [Related]

  • 15. Internal biliary drainage improves decreased number of gut mucosal T lymphocytes and MAdCAM-1 expression in jaundiced rats.
    Sano T, Ajiki T, Takeyama Y, Kuroda Y.
    Surgery; 2004 Sep 31; 136(3):693-9. PubMed ID: 15349120
    [Abstract] [Full Text] [Related]

  • 16. Dynamics of the HIV-1 latent reservoir after discontinuation of the intensification of antiretroviral treatment: results of two clinical trials.
    Gutiérrez C, Hernández-Novoa B, Vallejo A, Serrano-Villar S, Abad-Fernández M, Madrid N, Díaz L, Moreno A, Dronda F, Zamora J, Muñoz-Fernández MA, Moreno S.
    AIDS; 2013 Aug 24; 27(13):2081-8. PubMed ID: 24384589
    [Abstract] [Full Text] [Related]

  • 17. Macrophages accumulate in the gut mucosa of untreated HIV-infected patients.
    Allers K, Fehr M, Conrad K, Epple HJ, Schürmann D, Geelhaar-Karsch A, Schinnerling K, Moos V, Schneider T.
    J Infect Dis; 2014 Mar 01; 209(5):739-48. PubMed ID: 24133185
    [Abstract] [Full Text] [Related]

  • 18. Microbial Translocation Is Linked to a Specific Immune Activation Profile in HIV-1-Infected Adults With Suppressed Viremia.
    Younas M, Psomas C, Reynes C, Cezar R, Kundura L, Portales P, Merle C, Atoui N, Fernandez C, Le Moing V, Barbuat C, Moranne O, Sotto A, Sabatier R, Fabbro P, Vincent T, Dunyach-Remy C, Winter A, Reynes J, Lavigne JP, Corbeau P.
    Front Immunol; 2019 Mar 01; 10():2185. PubMed ID: 31572392
    [Abstract] [Full Text] [Related]

  • 19. Th17 cells, HIV and the gut mucosal barrier.
    Dandekar S, George MD, Bäumler AJ.
    Curr Opin HIV AIDS; 2010 Mar 01; 5(2):173-8. PubMed ID: 20543596
    [Abstract] [Full Text] [Related]

  • 20. Microbial translocation correlates with the severity of both HIV-1 and HIV-2 infections.
    Nowroozalizadeh S, Månsson F, da Silva Z, Repits J, Dabo B, Pereira C, Biague A, Albert J, Nielsen J, Aaby P, Fenyö EM, Norrgren H, Holmgren B, Jansson M.
    J Infect Dis; 2010 Apr 15; 201(8):1150-4. PubMed ID: 20199244
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.